跳至主要内容
临床试验/ACTRN12606000019505
ACTRN12606000019505招募中3 期

A Study to Evaluate the Impact of Patient Self Management on Oral Anticoagulation of Patients with Mechanical Heart Valve Replacement and/or Chronic Atrial Fibrillation

Royal Prince Alfred Hospital Cardiothoracic Department0 个研究点目标入组 300 人开始时间: 2006年1月13日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 ot stated(—)
性别
All

入选标准

  • 1. Patient has one or more mechanical valve(s) or chronic (greater than 3 months) Atrial Fibrillation. 2. Patient has been taking Warfarin/Coumadin for at least 3 months. 3. Patients INR has been in therapeutic range for > 2 weeks. 4. Patient has had no more than a <2mg change in their warfarin dose in the last four weeks. 5. Patient speaks English. 6. Patient can read English. 7. Patient has access to a telephone.

排除标准

  • 1. Patient is known to have a coagulation disorder2. Patient has known underlying liver disease3. Patient has a drug or alcohol addiction that is likely to limit compliance with the study routine.4. Patient has a visual deficit likely to limit compliance.5. Patient failed the mini mental test (AMT)6. Patient has any other condition that is likely to limit compliance (e.g. tremor or tactile dysfunction).

研究者

发起方
Royal Prince Alfred Hospital Cardiothoracic Department

相似试验